Early Drug Discovery Analiza specializes in physicochemical and ADME properties for early drug discovery, offering high quality, affordable analytical services. This presents opportunities to partner with pharma and biotech pipelines in need of rapid solubility, LogD, and pKa data to advance lead compounds.

Throughput and Cost Advantage With a history of automated miniaturized shake flask LogD and a focus on throughput and cost reductions, Analiza can be positioned as a scalable service provider for projects requiring frequent, small-batch testing and fast turnaround times.

Established Volume Having delivered tens of thousands of solubility measurements and tens of thousands of LogD measurements, Analiza demonstrates reliability and capacity, making it a credible partner for ongoing ADME profiling in large or expanding pipelines.

Geographic Footprint Based in Cleveland with a US-centric approach, Analiza can target North American biotech clusters and regional pharma collaborations, offering localized support, faster communication, and potential co-development opportunities.

Growth and Funding Signals Revenue in the low-mid millions indicates room for scale and expanded service lines. This suggests potential upsell opportunities into broader physchem, ADME, and analytical services as clients grow or diversify their discovery portfolios.